http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Cataract/Article/list/416 Cataract treatments such as phacoemulsification, intraocular lenses (IOLs), as well as ophthalmic viscosurgical devices (OVDs), and other options such as corneal tension rings (CTRs). 2009-11-21T15:40:28Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Industry+News/Bausch-amp-Lomb-subsidiaries-CROMA-to-co-promote-b/ArticleStandard/Article/detail/631233?contextCategoryId=416&ref=25 Several subsidiaries of Bausch & Lomb have been granted rights from CROMA Pharma GmbH to co-promote and sell bromfenac ophthalmic solution in Europe when it becomes available to that market, announced Bausch & Lomb. 2009-10-02T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/412009/631233null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Industry+News/AMO-launches-online-ordering-service/ArticleStandard/Article/detail/631232?contextCategoryId=416&ref=25 Abbott Medical Optics (AMO) has launched a new online ordering service (AMOeasy, www.amoeasy.com) whereby customers can order the company?s implants and other cataract-related products as well as track orders at any time of day. 2009-10-02T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/412009/631232null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/World-Sight-Day-set-for-Oct-8/ArticleStandard/Article/detail/631236?contextCategoryId=416&ref=25 Three hundred events in more than 50 countries will mark this year's World Sight Day, Oct. 8. 2009-10-02T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/412009/631236null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/Femtosecond-laser-receives-clearance-for-capsuloto/ArticleStandard/Article/detail/626558?contextCategoryId=416&ref=25 LenSx Lasers Inc. announced that the FDA has granted 510(k) clearance for its femtosecond laser used for anterior capsulotomy during cataract surgery. 2009-09-16T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/382009/626558null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Sulcus-placement-of-a-proprietary-three-piece-mult/ArticleStandard/Article/detail/627822?contextCategoryId=416&ref=25 Sulcus placement of a proprietary three-piece multifocal IOL (ReZoom, Abbott Medical Optics) is a viable option in eyes in which capsular bag support is not adequate to ensure good lens stability. Then, if the lens decenters in the sulcus, scleral suturing is a safe and effective option for recentering the IOL and restoring good vision. 2009-09-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/382009/627822null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Eye-care-patient-satisfaction-is-weighed-with-onli/ArticleStandard/Article/detail/627821?contextCategoryId=416&ref=25 The co-authors conducted two studies to determine patient satisfaction related to their cataract-IOL surgeries, based on online health forums. 2009-09-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/382009/627821null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/ISTA-to-seek-bromfenac-label-change/ArticleStandard/Article/detail/623208?contextCategoryId=416&ref=25 ISTA Pharmaceuticals plans to ask the FDA to approve a change to the label of its bromfenac 0.09% ophthalmic solution after obtaining positive preliminary phase III results in a confirmatory clinical study of once-daily bromfenac (Xibrom QD) for the treatment of inflammation and pain after cataract surgery. 2009-09-02T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/362009/623208null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Microincisional-IOL-debuts-for-cataract-surgery/ArticleStandard/Article/detail/627654?contextCategoryId=416&ref=25 The first microincisional IOL (Akreos MICS IOL, Bausch & Lomb) has been introduced in the U.S. market. The lens is a single-piece hydrophilic acrylic IOL designed for delivery through a 1.8-mm incision. Its material and design offer several advantages, according to three surgeons who have used it. 2009-09-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/382009/627654null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/Anti-inflammatory-for-cataract-surgery-reaches-pha/ArticleStandard/Article/detail/621767?contextCategoryId=416&ref=25 Preliminary phase III results were released for bromfenac ophthalmic solution 0.09% (Xibrom, ISTA Pharmaceuticals), meant to treat the inflammation and pain following cataract surgery. 2009-08-26T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352009/621767null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/Survey-shows-cataract-surgery-times-can-be-decreas/ArticleStandard/Article/detail/619783?contextCategoryId=416&ref=25 Ambulatory centers performing cataract extraction with lens insertion can reduce their procedure times and improve efficiencies, safety, and patient satisfaction, according to a survey conducted by the Accreditation Association for Ambulatory Health Care Institute for Quality Improvement. 2009-08-19T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342009/619783null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/23-sodium-hyaluronate-functions-as-unique-surgical/ArticleStandard/Article/detail/619327?contextCategoryId=416&ref=25 An ophthalmic viscosurgical device of 2.3% sodium hyaluronate (Healon 5, Abbott Medical Optics) makes one ophthalmologist's prechopping-assisted phacoemulsification technique safer and easier, he says. 2009-08-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342009/619327null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/IOL-explantation-trends-shifting-American-Society-/ArticleStandard/Article/detail/619324?contextCategoryId=416&ref=25 The most recent results from the 2008 American Society of Cataract and Refractive Surgery/European Society of Cataract and Refractive Surgeons survey on foldable IOLs requiring removal or other secondary intervention highlight changes over time in the complications associated with various lens types. 2009-08-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342009/619324null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Dispersive-cohesive-ophthalmic-surgical-device-out/ArticleStandard/Article/detail/619330?contextCategoryId=416&ref=25 One surgeon's preference for an ophthalmic surgical device (OVD) of 1.6% sodium hyaluronate (Amvisc Plus, Bausch & Lomb) was reinforced by a study that found it superior to another OVD during phaco and OVD removal. 2009-08-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342009/619330null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Biaxial-phaco-with-torsional-ultrasound-enhanced-w/ArticleStandard/Article/detail/619328?contextCategoryId=416&ref=25 A new phaco tip (Fine OZil Tip, MicroSurgical Technology) for use with a proprietary handpiece (OZil, Alcon Laboratories) improves the safety and efficiency of phacoemulsification using torsional ultrasound with a biaxial microincisional technique. Modification of the phaco parameters improves chopping and segment removal. 2009-08-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342009/619328null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Fluidics-controlled-longitudinal-transversal-phaco/ArticleStandard/Article/detail/619322?contextCategoryId=416&ref=25 The current version of a proprietary phaco system (WhiteStar Signature, Abbott Medical Optics) features fluidics control software that allows automatic switching from longitudinal ultrasound to transversal (Ellips) on recognition of occlusion and back again to longitudinal on occlusion break. Results of a prospective study show the benefits of this technology for optimizing the efficiency of cataract removal. 2009-08-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342009/619322null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Dual-linear-phacoemulsification-platform-separates/ArticleStandard/Article/detail/619333?contextCategoryId=416&ref=25 A dual-linear phacoemulsification platform (available on the Stellaris, Bausch & Lomb) separates phaco and vacuum, allowing cataract surgeons to maximize their control over the cataract removal procedure. 2009-08-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342009/619333null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Ketorolac-tromethamine-045-approved-by-FDA/ArticleStandard/Article/detail/619323?contextCategoryId=416&ref=25 Ketorolac tromethamine 0.45% (Acuvail, Allergan) is a preservative-free ophthalmic NSAID recently approved for twice-daily use in treating pain and inflammation after cataract surgery. Its novel formulation is designed to promote drug delivery and tolerability. 2009-08-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342009/619323null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Ophthalmic-viscosurgical-device-choices-mean-optim/ArticleStandard/Article/detail/619331?contextCategoryId=416&ref=25 The large variety of available OVDs allows the surgeon to tailor the surgery to meet any specific needs a patient may have. 2009-08-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342009/619331null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Eyes-with-intraoperative-floppy-iris-syndrome-are-/ArticleStandard/Article/detail/619325?contextCategoryId=416&ref=25 Surgeons discuss their preferences and techniques for using various ophthalmic viscosurgical devices in eyes with intraoperative floppy iris syndrome. 2009-08-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342009/619325null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/Researchers-uncover-genetic-link-to-age-related-ca/ArticleStandard/Article/detail/615695?contextCategoryId=416&ref=25 Researchers in Cleveland have discovered the first gene associated with the formation of age-related cataracts. 2009-08-05T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/312009/615695null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Cataract/Ketolorac-tromethamine-should-be-available-in-Sept/ArticleStandard/Article/detail/615682?contextCategoryId=416&ref=25 Allergan Inc. expects its ketorolac tromethamine ophthalmic solution 0.45% (Acuvail) to be available in the United States in September. 2009-08-05T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/312009/615682null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Tamsulosin-intraoperative-floppy-iris-syndrome-lin/ArticleStandard/Article/detail/617060?contextCategoryId=416&ref=25 A recent article in the Journal of the American Medical Association, an editorial in American Family Physician, articles in the general media outlets, and an updated patient advisory statement from the American Society of Cataract and Refractive Surgery and the American Academy of Ophthalmology aim to further education primary care physicians and patients about the association between a patient's use of tamsulosin and complications or difficulty during cataract surgery. 2009-08-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322009/617060null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Pars-plana-vitrectomy-risks-mandate-careful-undert/ArticleStandard/Article/detail/617061?contextCategoryId=416&ref=25 Cataract surgeons confronted by capsular rupture with vitreous prolapse usually favor performing limbal vitrectomy over using a pars plana approach. 2009-08-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322009/617061null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Moxifloxacin-soaked-IOLs-provide-clinically-releva/ArticleStandard/Article/detail/617070?contextCategoryId=416&ref=25 A hydrophilic IOL (Afinity CQ2015, STAAR Surgical) seems to be a more efficient delivery system of moxifloxacin 0.5% (Vigamox, Alcon Laboratories) than a hydrophobic IOL (AcrySof SA60, Alcon Laboratories), according to the results of a comparison of lenses soaked in the antibiotic. Both lenses appear to be capable of delivering antibiotics to achieve clinically relevant levels, however. 2009-08-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322009/617070null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Negative-dysphotopsia-an-enigma/ArticleStandard/Article/detail/606443?contextCategoryId=416&ref=25 Negative dysphotopsia can lead to tremendous dissatisfaction in patients with pseudophakia. 2009-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262009/606443null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Dual-optic-accommodating-IOL-provides-superior-acu/ArticleStandard/Article/detail/606439?contextCategoryId=416&ref=25 In a prospective, randomized trial of 90 bilateral cataract patients, those who received an investigational dual-optic accommodating IOL (Synchrony, Visiogen) had better visual acuity and higher reading speeds at intermediate distances compared with patients who received an apodized diffractive multifocal IOL (AcrySof ReSTOR, Alcon Laboratories). 2009-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262009/606439null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Coaxial-microincisional-cataract-surgery-results-i/ArticleStandard/Article/detail/606441?contextCategoryId=416&ref=25 Results of a retrospective study comparing groups of eyes undergoing phacoemulsification using a coaxial 1.8-mm microincisional technique versus through a standard 2.8-mm incision showed that the flare/cell reaction in the anterior chamber early after surgery was significantly less in the microincisional group. 2009-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262009/606441null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Optical-biometer-provides-more-data-than-original-/ArticleStandard/Article/detail/606437?contextCategoryId=416&ref=25 In a side-by-side comparison of 35 patients, a new optical biometer (LenStar LS900, Haag-Streit) was found to provide more data per examination than the only previously available optical biometer (IOLMaster, Carl Zeiss Meditec), but the examination with the new model took longer to complete. 2009-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262009/606437null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Lens-epithelial-cells-effectively-removed-from-cap/ArticleStandard/Article/detail/606438?contextCategoryId=416&ref=25 An in vitro study was performed evaluating laser photolysis using a modified Nd:YAG laser (A.R.C. Laser) to remove lens epithelial cells (LECs) from the capsular bag. 2009-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262009/606438null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Transversal-ultrasound-Phacoemulsification-with-le/ArticleStandard/Article/detail/606435?contextCategoryId=416&ref=25 Transversal ultrasound that blends side-to-side and longitudinal ultrasound into an elliptical movement is an effective phacoemusification tool, particularly for dense cataracts. In an open-label, non-randomized comparative study of 331 patients who received phaco via a transversal ultrasound system, average effective phaco time and average foot pedal time were both very low. The elliptical motion of transversal ultrasound also reduces repulsion, does not require a bent needle, is useful for trenching and sculpting, and is self-cleaning of nuclear debris. 2009-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262009/606435null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Cataract-surgery-Phacoemulsification-fluidics-char/ArticleStandard/Article/detail/606434?contextCategoryId=416&ref=25 Better understanding of the effects of ultrasound modality as well as phacoemulsification tip type and orientation can help to optimize the efficiency and safety of cataract surgery. Jaime Zacharias, MD, has implemented novel methodology to gather this information. 2009-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262009/606434null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/The-future-of-cataract-surgery-Improved-ergonomics/ArticleStandard/Article/detail/606444?contextCategoryId=416&ref=25 A "heads up" high-definition, three-dimensional (3-D) system allows surgeons to perform cataract procedures without hunching over a standard microscope. In addition to the improved ergonomics, the system has wide-ranging applications for patient and surgeon education, and by using the 3-D format and overlaying graphics and metrics, holds promise to optimize results and safety margins in cataract surgery and other procedures. 2009-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262009/606444null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Lens-epithelial-cell-evacuation-techniques-not-suf/ArticleStandard/Article/detail/606433?contextCategoryId=416&ref=25 Current methods used to evacuate the capsule of lens epithelial cells and other lens material are not sufficient to prevent late complications stemming from the resultant Soemmerring's ring formation, namely posterior capsule opacification in adults and unwanted fibrosis in children after cataract surgery, according to the results of one study. Therefore, the researchers suggest that new approaches to basic phacoemulsification should be explored. 2009-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262009/606433null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Endophthalmitis-risk-can-be-reduced-by-the-right-a/ArticleStandard/Article/detail/606440?contextCategoryId=416&ref=25 In a 10-year study of more than 30,000 cataract extractions, faulty wounds were found to be the number one risk factor for the development of endophthalmitis. Appropriate antibiotic therapy also should be in place during and immediately after surgery, because delaying antibiotics to postoperative day 1 increased the risk of endophthalmitis more than 13-fold, according to the study results. 2009-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262009/606440null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Simultaneous-bilateral-cataract-surgery-a-safe-pro/ArticleStandard/Article/detail/606436?contextCategoryId=416&ref=25 Although many ophthalmic surgeons avoid performing simultaneous bilateral cataract surgery because of the perceived risk of bilateral simultaneous endophthalmitis, the risk of the complication is actually miniscule when proper infection control and anti-cross-contamination procedures are followed. As refractive lens procedures are increasingly performed on younger patients, it is likely that the simultaneous bilateral procedure will become more common. 2009-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/262009/606436null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Cataract/AAO-ASCRS-issue-advisory-to-cataract-patients-taki/ArticleStandard/Article/detail/602877?contextCategoryId=416&ref=25 The American Academy of Ophthalmology (AAO) and the American Society of Cataract and Refractive Surgery (ASCRS) have issued a joint statement regarding results of a new study. The new research reinforces an advisory issued in 2006 that cautioned patients taking tamsulosin (Flomax, Boehringer Ingelheim Pharmaceuticals Inc.) to treat prostate enlargement and urinary problems should inform their ophthalmologist about use of this alpha-blocker before undergoing eye surgery. 2009-06-10T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/242009/602877null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/Corneal-edema-patients-at-higher-risk-for-transpla/ArticleStandard/Article/detail/601688?contextCategoryId=416&ref=25 The corneal transplant failure rate was four times higher in patients diagnosed with corneal edema associated with either IOL implants or no natural lens following cataract removal, than in patients diagnosed with Fuchs' dystrophy, according to a study. 2009-06-04T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/232009/601688null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Toric-IOL-rotational-stability-is-demonstrated-in-/ArticleStandard/Article/detail/599635?contextCategoryId=416&ref=25 Postoperative rotation of a toric IOL (AcrySof Toric/SN60TT, Alcon Laboratories) was investigated in 30 eyes through analysis of retroillumination photographs taken at 1 hour, 1 month, and 6 months after surgery. 2009-05-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599635null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Wanted-Test-to-screen-multifocal-IOL-candidates-fo/ArticleStandard/Article/detail/599633?contextCategoryId=416&ref=25 Multifocal IOLs add "noise" to the visual system that can challenge the neural-adaptation abilities of some patients. While the Pelli-Levi Dual Acuity Chart is an effective screen for neuro-sensory pathology, one practitioner said what's needed is a test that will help ophthalmologists identify patients who are likely to have difficulty neural-adapting to a multifocal IOL. 2009-05-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599633null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Multifocal-IOL-mixing-and-matching-is-found-to-be-/ArticleStandard/Article/detail/599628?contextCategoryId=416&ref=25 Twelve European centers participated in a prospective Web-documented study to investigate mixing and matching of multifocal IOLs with different optical principles. Results from 152 patients seen at a final visit (120 to 180 days after surgery) showed excellent outcomes for visual acuity, functional near vision, and spectacle independence along with a high rate of patient satisfaction. 2009-05-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599628null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Dual-optic-accommodating-IOL-displays-excellent-in/ArticleStandard/Article/detail/599624?contextCategoryId=416&ref=25 A randomized trial of 120 eyes in 60 patients compared an investigational dual optic accommodating IOL (Synchrony, Visiogen) with an apodized diffractive aspheric multifocal IOL (AcrySof ReSTOR Aspheric, Alcon Laboratories). Preliminary results in 31 eyes of 18 patients 6 months postoperatively found that distance-corrected distance and near visual results were comparable between the two IOLs and that the dual optic accommodating IOL provided significantly better intermediate visual acuity. 2009-05-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599624null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Toric-IOLs-can-be-oriented-by-iris-fingerprinting/ArticleStandard/Article/detail/599622?contextCategoryId=416&ref=25 Toric IOLs are precision devices that improve the vision of patients who have cataracts and astigmatism. A new method for orienting these lenses with absolute accuracy, using unique iris landmarks and proprietary software to graph and map it, is designed to help ensure that these lenses are of optimal benefit to these patients. 2009-05-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599622null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Bifocal-IOL-favorable-option-for-cataract-and-refr/ArticleStandard/Article/detail/599632?contextCategoryId=416&ref=25 Data were collected from a series of 29 patients who underwent bilateral implantation of the aberration-correcting bifocal IOL (Acri.Lisa 366D, Carl Zeiss Meditec). The results are favorable for refractive predictability and both visual acuity and self-rated performance for a variety of daily activities. The majority of patients achieved complete spectacle independence. 2009-05-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599632null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Aspheric-multifocal-IOL-study-highlights-benefits-/ArticleStandard/Article/detail/599634?contextCategoryId=416&ref=25 A prospective, multicenter clinical trial randomly assigned 279 patients to bilateral implantation of the +3.0-D add power multifocal AcrySof IQ ReSTOR IOL (SN6AD1, Alcon Laboratories) or the +4.0-D add power version (SN6AD3, Alcon Laboratories). Assessments at 6 months after surgery, including binocular defocus testing, showed the theoretically expected shift in the best distance for near vision and a significant improvement in intermediate vision with the +3.0-D versus the +4.0-D ReSTOR IOL. 2009-05-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599634null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Aspheric-diffractive-multifocal-IOL-performance-hi/ArticleStandard/Article/detail/599627?contextCategoryId=416&ref=25 In a U.S. multicenter study, 121 patients underwent bilateral implantation of the aspheric diffractive multifocal IOL (Tecnis Multifocal ZMA00, Abbott Medical Optics). At 1 year, 93% of patients achieved simultaneous distance UCVA of 20/25 or better and 20/32 (~J2) at near (despite disallowing the correction of astigmatism), and about 85% never wore glasses. Unique design features help to explain the outstanding performance of this new multifocal IOL. 2009-05-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599627null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Accommodating-lens-offers-improved-visual-acuity-m/ArticleStandard/Article/detail/599619?contextCategoryId=416&ref=25 A multicenter postmarketing study is under way assessing the effectiveness of the latest generation of an accommodating IOL (Crystalens HD, Bausch & Lomb). Initial results from a 1-month visit show that the lens is associated with a full range of functional vision and improved visual acuities relative to the previous generation of this presbyopia-correcting IOL. 2009-05-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599619null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Cataract/Study-compares-M-SICS-phaco-in-charity-camp-popula/ArticleStandard/Article/detail/596431?contextCategoryId=416&ref=25 To answer the question of whether quality - specifically, uncorrected vision, astigmatism, visual rehabilitation, and safety - is sacrificed when M-SICS is performed instead of phaco, Sanduk Ruit, MD, Geoffrey Tabin, MD, David F. Chang, MD, and colleagues conducted the first prospective, randomized trial of phaco versus M-SICS in a charity camp population. 2009-05-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/192009/596431null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Astigmatism-measurement-improves-refractive-result/ArticleStandard/Article/detail/599655?contextCategoryId=416&ref=25 Astigmatism measurement with an intraoperative wavefront aberrometer (ORange, WaveTec Vision Systems) allows evaluation of the effect of limbal relaxing incisions during cataract surgery and the need for enhancement. Results of a multicenter study show that its readings correspond with topographic and refractive cylinder measured preoperatively and postoperatively and that its use improves postoperative refractive results. 2009-05-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599655null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Cataract-Three-programs-offer-hope-in-developing-w/ArticleStandard/Article/detail/599640?contextCategoryId=416&ref=25 Three programs in different geographic areas serve as models of success in addressing cataract in the developing world, the top cause of blindness globally. 2009-05-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/222009/599640null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Cataract/ASCRS-New-intraoperative-wavefront-aberrometer-deb/ArticleStandard/Article/detail/591938?contextCategoryId=416&ref=25 San Francisco—Refractive-cataract surgeons now have a tool to guide the outcomes of their cataract procedures (ORange Intraoperative Wavefront Aberrometer, WaveTec Vision). 2009-04-06T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/152009/591938null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Cataract/ASCRS-Two-year-data-Canaloplasty-combined-with-pha/ArticleStandard/Article/detail/591748?contextCategoryId=416&ref=25 San Francisco—The combination of canaloplasty and phacoemulsification surgery in patients who have both cataracts and primary open-angle glaucoma (POAG) results in a dramatic decrease in both IOP and the number of anti-glaucoma medications patients must take. Bradford J. Shingleton, MD, a glaucoma and cataract specialist with Ophthalmic Consultants of Boston, presented 2-year results of an ongoing prospective, randomized international study of canaloplasty in patients with POAG who also presented with a visually significant cataract. 2009-04-05T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/152009/591748null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Cataract/ASCRS-3D-flat-panel-displays-available-for-operati/ArticleStandard/Article/detail/591706?contextCategoryId=416&ref=25 San Francisco—New three-dimensional (3D) flat-panel displays (TrueVision Systems Inc.) will enable cataract and refractive surgeons to display live and recorded content of the surgical view from a microscope or slit lamp. 2009-04-04T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/142009/591706null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Cataract/ASCRS-Binkhorst-Lecture-Three-programs-offer-hope-/ArticleStandard/Article/detail/591709?contextCategoryId=416&ref=25 San Francisco—Three programs in different geographic areas of the world serve as models of success in addressing cataract, the top cause of blindness globally, said David F. Chang, MD, who delivered the Binkhorst Lecture during the opening session. 2009-04-04T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/152009/591709null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Cataract/ASCRS-Training-program-helps-surgeons-boost-premiu/ArticleStandard/Article/detail/591707?contextCategoryId=416&ref=25 San Francisco—The first session of a unique training program, Premium Lens Boot Camp, to help refractive and cataract surgeons grow their accommodating/multifocal lens business will be held June 5 at the O'Hare Marriott, Chicago. 2009-04-04T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/142009/591707null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Cataract-surgery-outcomes-better-predicted-by-mete/ArticleStandard/Article/detail/593670?contextCategoryId=416&ref=25 Patients undergoing phacoemulsification were evaluated preoperatively with a proprietary device (Retinal Acuity Meter, AMA Optics) and a dilated near card through a potential acuity pinhole technique. Predictions of postoperative distance acuity were significantly more accurate using the meter. Design features of the device that standardize testing conditions and eliminate patient confusion during reading likely account for its superior performance. 2009-04-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/162009/593670null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Anterior-chamber-versus-suture-fixated-poster-cham/ArticleStandard/Article/detail/593671?contextCategoryId=416&ref=25 There have been few trials adequately structured to compare different IOL options in eyes without adequate capsular bag support, and none provides clear evidence for the superiority of an anterior chamber, iris sutured posterior chamber (PC), or scleral sutured PC IOL. IOL selection should be based on surgeon experience and patient-related factors. 2009-04-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/162009/593671null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Outcomes-with-microcoaxial-versus-standard-coaxial/ArticleStandard/Article/detail/593672?contextCategoryId=416&ref=25 Phacoemulsification using the OZil torsional handpiece and the INFINTI Vision System (Alcon Laboratories) was performed in 32 patients undergoing bilateral cataract surgery using a standard 2.8-mm coaxial incision in the right eye and a 2.2-mm microcoaxial incision in the left eye. There were statistically significant differences favoring the microcoaxial procedure in cumulative dissipated energy intraoperatively and endothelial cell loss after 6 months. These benefits were achieved without any compromise of incision integrity. 2009-04-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/162009/593672null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Aspheric-toric-IOL-for-cataracts-is-approved-by-th/ArticleStandard/Article/detail/593669?contextCategoryId=416&ref=25 Alcon Laboratories has gained FDA approval to market an aspheric version of its astigmatism-correcting IOL, the AcrySof IQ Toric IOL. With this new platform, cataract surgeons can continue to provide precise reduction of astigmatism and excellent distance visual acuity outcomes, while patients will benefit further with improved image quality and contrast sensitivity. 2009-04-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/162009/593669null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/IOL-dislocation-management-differentiated-by-compl/ArticleStandard/Article/detail/589230?contextCategoryId=416&ref=25 Approaches for managing a dislocated posterior chamber IOL each have their advantages and disadvantages. Results of a retrospective study including more than 300 eyes show that whether the IOL is exchanged or repositioned with suturing and whether the suturing is to the sclera or the iris, the functional outcome is similar on average, and safety is favorable. Complication profiles mainly distinguish the various techniques. 2009-03-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589230null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Modern+Medicine+Now/Capsulorhexis-The-most-important-step-in-phacoemul/ArticleStandard/Article/detail/589231?contextCategoryId=416&ref=25 The capsulorhexis is perhaps the most important step in phacoemulsification for guaranteeing a good outcome. A well-centered and adequately sized rhexis that overlaps the IOL optic slightly for 360° is the ideal and for the most part, this is easily achieved in routine cases. However, alterations in technique and sizing may be necessary or desirable in difficult and challenging cases such as advanced nuclear sclerosis, pseudoexfoliation, posterior polar cataract, or subluxed lenses. 2009-03-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/132009/589231null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/Improved-cataract-surgery-lowers-infection-rates/ArticleStandard/Article/detail/585455?contextCategoryId=416&ref=25 Endophthalmitis continues to be rare after cataract surgery, according to a study by Canadian researchers. 2009-03-06T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/102009/585455null HTML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Clinical+News/AMD-not-made-worse-by-cataract-surgery-according-t/ArticleStandard/Article/detail/584514?contextCategoryId=416&ref=25 According to new research, cataract surgery does not hasten vision loss in people with age-related macular degeneration (AMD). 2009-03-03T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/102009/584514null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/IOP-lowering-benefits-of-cataract-surgery-more-sig/ArticleStandard/Article/detail/585655?contextCategoryId=416&ref=25 Cataract surgery can dramatically lower elevated IOP, and the effect appears to be quite durable. This benefit, together with the safety of phacoemulsification, suggests that ophthalmologists should consider its role as a stand-alone procedure to treat co-morbid cataract and glaucoma. 2009-03-01T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/102009/585655null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Capsulorhexis-tear-out-salvaged-by-simple-maneuver/ArticleStandard/Article/detail/585656?contextCategoryId=416&ref=25 When capsulorrhexis becomes complicated by a radial tear, pulling the flap backward, first circumferentially and then centrally, can rescue the tear-out. Here, an ophthalmologist shares a technique to successfully address this complication. 2009-03-01T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/102009/585656null XML http://www.modernmedicine.com/modernmedicine/Clinical+News/Cataracts-and-AMD-may-be-prevented-by-exercise-acc/ArticleStandard/Article/detail/582274?contextCategoryId=416&ref=25 Vigorous exercise may help prevent age-related macular degeneration and cataracts, according to a new study. 2009-02-18T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/082009/582274null HTML http://www.modernmedicine.com/modernmedicine/Cataract+News/Accommodating-IOL-ad-campaign-for-seniors-launched/ArticleStandard/Article/detail/579483?contextCategoryId=416&ref=25 Bausch & Lomb launched a new advertising campaign geared toward baby boomers and seniors about its FDA-approved accommodating IOL (Crystalens). 2009-02-04T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/062009/579483null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Multifocal-IOL-is-approved-by-FDA/ArticleStandard/Article/detail/580293?contextCategoryId=416&ref=25 The FDA approved a multifocal IOL (Tecnis, Advanced Medical Optics) for implantation in patients with cataract and presbyopia. 2009-02-01T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/062009/580293null XML http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/Industry+News/FDA-approves-multifocal-IOL/ArticleStandard/Article/detail/576432?contextCategoryId=416&ref=25 Advanced Medical Optics has received FDA approval for a multifocal IOL (Tecnis) for patients with cataracts. 2009-01-20T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/042009/576432null HTML http://www.modernmedicine.com/modernmedicine/Clinical+News/Cataracts-could-be-detected-early-with-NASA-device/ArticleStandard/Article/detail/576381?contextCategoryId=416&ref=25 Researchers are studying the use of a NASA device to reveal the development of cataracts before a patient's vision clouds over. 2009-01-20T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/042009/576381null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataracts-presbyopia-lens-approved-by-FDA/ArticleStandard/Article/detail/577630?contextCategoryId=416&ref=25 The FDA last month approved a lens (AcrySof IQ ReSTOR +3 D, Alcon Laboratories) designed for implantation in patients with cataract and presbyopia. 2009-01-15T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/052009/577630null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Pars-plana-approach-can-provide-successful-outcome/ArticleStandard/Article/detail/573450?contextCategoryId=416&ref=25 Posterior capsule rupture with vitreous prolapse remains one of the most serious intraoperative complications during cataract surgery. Louis D. "Skip" Nichamin, MD, describes the benefits and technique for anterior vitrectomy using a pars plana approach. 2009-01-01T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/012008/573450null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Triamcinolone-staining-useful-aid-for-vitrectomy/ArticleStandard/Article/detail/573451?contextCategoryId=416&ref=25 Intracameral injection of triamcinolone is very useful for "staining" vitreous that has prolapsed into the anterior segment to enable vitrectomy. Safety is favorable, but there are some issues to consider. 2009-01-01T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/012008/573451null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Cataract-2008-A-year-in-review/ArticleStandard/Article/detail/568130?contextCategoryId=416&ref=25 Cataract surgery is a modern success story because of the advances in techniques and technology that have been made over the years. Excellent outcomes are becoming routine, and the field only continues to progress, thanks to a steady stream of innovations. Three cataract surgeons share their thoughts on some of the most noteworthy innovations and trends of 2008 and beyond. 2008-12-01T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/482008/568130null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Anticipate-silodosin-intraoperative-floppy-iris-sy/ArticleStandard/Article/detail/568123?contextCategoryId=416&ref=25 History-taking is a little more time-consuming for cataract surgeons with the recent FDA approval of silodosin capsules (Rapaflo, Watson) for the treatment of symptoms due to benign prostatic hyperplasia. 2008-12-01T05:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/482008/568123null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Newer-one-piece-IOL-offers-excellent-visual-acuity/ArticleStandard/Article/detail/560453?contextCategoryId=416&ref=25 The state-of-the-art material and design of a novel one-piece IOL can offer refractive stability and predictability, according to Daniel A. Black, MBBS, FRACO, FRACS. This newer IOL rivals other more established IOLs and may soon become the gold-standard treatment in cataract procedures, he said. 2008-11-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/560453null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Severity-determines-intraoperative-floppy-iris-syn/ArticleStandard/Article/detail/560451?contextCategoryId=416&ref=25 A cataract surgeon who first identified intraoperative floppy iris syndrome (IFIS) and its association with tamsulosin describes several approaches to managing the surgical complication. The approach a surgeon uses will depend on the severity of IFIS, he says. 2008-11-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/560451null XML http://www.modernmedicine.com/modernmedicine/Cataracts/ESCRS-Endophthalmitis-Study-Intracameral-cefuroxim/ArticleStandard/Article/detail/560450?contextCategoryId=416&ref=25 Prophylactic intracameral cefuroxime injections prevent the development of endophthalmitis after cataract surgery, according to results of the European Society of Cataract and Refractive Surgeons Endophthalmitis Study. The finding remains controversial in the United States, where cefuroxime has not been approved by the FDA and the standard of care to prevent endophthalmitis after cataract surgery is the administration of preoperative, perioperative, and postoperative topical fluoroquinolone drops. 2008-11-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/560450null XML http://www.modernmedicine.com/modernmedicine/Cataracts/2-year-data-promising-for-dual-optic-lens-centers-/ArticleStandard/Article/detail/560452?contextCategoryId=416&ref=25 Two lenses may be better than one. In a prospective trial of 30 eyes, a dual-accommodating IOL, with a high-diopter anterior optic and a minus-power posterior optic, provided good distance visual acuity, depth of focus, and a good safety profile. 2008-11-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/560452null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Guarded-surgical-knives-designed-to-maintain-sharp/ArticleStandard/Article/detail/559845?contextCategoryId=416&ref=25 New guarded knives (Sharpoint, Angiotech) retain their sharpness far longer than other disposable blades, and this durability translates into the ability to perform more procedures with the same instrument and to make cleaner, faster-healing incisions, according to one ophthalmologist. 2008-10-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/559845null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Advances-in-cataract-surgery-bring-new-complicatio/ArticleStandard/Article/detail/559846?contextCategoryId=416&ref=25 Cataract surgical techniques and IOLs have both been evolving for many years. The advances have been—and continue to be—tremendous, but each new advance also has the potential to give birth to new complications. The need to suture clear corneal incisions to prevent potentially blinding complications during subsequent surgery, and the dislocation of one-piece IOLs and capsular tension rings, are examples of complications of which practitioners need to be aware. 2008-10-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/559846null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Phaco-machine-settings-may-not-match-delivery/ArticleStandard/Article/detail/559844?contextCategoryId=416&ref=25 In a fluidics test of three phacoemulsification machines, differences were found in vacuum, flow, and postocclusion surge—and these differences were found not only between the three machines but also between the machines' own settings and what they were actually delivering. Other important findings: there is a significant amount of unoccluded vacuum at the tip, and the parameters for what constitutes a safe postocclusion surge can be dramatically different among eyes. 2008-10-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/559844null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Near-vision-with-a-monofocal-aspheric-IOL/ArticleStandard/Article/detail/559843?contextCategoryId=416&ref=25 In the current era of presbyopia-correcting IOLs, toric IOLs, and aspheric IOL technology, the practice milieu is changing. 2008-10-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/432008/559843null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Technology-investigational-aberrometer-offers-real/ArticleStandard/Article/detail/556867?contextCategoryId=416&ref=25 An aberrometer is being developed to provide cataract and refractive surgeons with a tool for intraoperative assessment of refraction to improve results of astigmatic correction techniques and IOL power selection. Outcomes in an ongoing clinical trial are encouraging. 2008-10-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/412008/556867null XML http://www.modernmedicine.com/modernmedicine/Cataract/Prepare-for-hyperopic-shift-following-DSAEK-graft-/ArticleStandard/Article/detail/553278?contextCategoryId=416&ref=25 A retrospective study including 45 eyes that underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) found an average refractive change of +0.88 D after surgery. That hyperopic shift after DSAEK has implications for management of patients undergoing cataract surgery simultaneously with or after DSAEK and for anticipating refractive outcomes in pseudophakic patients undergoing DSAEK. 2008-10-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/553278null HTML http://www.modernmedicine.com/modernmedicine/Cataracts/Cefuroxime-intracameral-versus-subconjunctival-inj/ArticleStandard/Article/detail/556866?contextCategoryId=416&ref=25 Intracameral injection of cefuroxime significantly reduced the risk of endophthalmitis following cataract surgery when compared with subconjunctival injection in a single-center study. 2008-10-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/412008/556866null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Changes-to-surgical-routine-cut-risk-of-postoperat/ArticleStandard/Article/detail/551966?contextCategoryId=416&ref=25 A cluster of cases of postoperative endophthalmitis at the Prince Charles Eye Unit, King Edward Hospital, Windsor, England, over a 4-month period led to a thorough investigation of etiologic factors and multiple changes in the perioperative routines. 2008-09-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551966null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Phaco-philosophy-consider-IOL-exchange-pearls-prac/ArticleStandard/Article/detail/551965?contextCategoryId=416&ref=25 Exchanging an IOL is the only choice when the optical clarity of the implant is compromised by internal calcification or glistenings. 2008-09-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/392008/551965null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Vision-system-enables-easy-transition-to-coaxial-M/ArticleStandard/Article/detail/548852?contextCategoryId=416&ref=25 A prospective evaluation of the first 50 cases of coaxial microincision cataract surgery performed with a vision enhancement system (Stellaris, Bausch & Lomb) shows that the platform facilitates adoption of this new surgical technique and allows surgery to be performed with higher levels of vacuum, less dependence on ultrasound, and excellent anterior chamber stability. 2008-09-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/372008/548852null XML http://www.modernmedicine.com/modernmedicine/Cataracts/High--and-low-frequency-phaco-energy-behave-differ/ArticleStandard/Article/detail/548851?contextCategoryId=416&ref=25 High- and low-frequency energy in porcine and human eyes displayed on an oscilloscope showed that the energy levels behave differently in the eye during phacoemulsification. 2008-09-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/372008/548851null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Reduced-phaco-time-observed-with-use-of-oscillatio/ArticleStandard/Article/detail/548853?contextCategoryId=416&ref=25 Use of an oscillation device (NeoSoniX handpiece, Alcon Laboratories) results in a shorter phacoemulsification time compared with the time in cases in which a conventional handpiece was used. This difference may result in less phaco energy use in the eye, less trauma during surgery, more rapid visual rehabilitation postoperatively, and perhaps less loss of endothelial cells. 2008-09-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/372008/548853null XML http://www.modernmedicine.com/modernmedicine/Cataracts/Imaging-system-takes-OR-microscope-to-next-level/ArticleStandard/Article/detail/548854?contextCategoryId=416&ref=25 As imaging continues to move in the direction of digital technology, one such vision platform (3-D HD, TrueVision) takes a stereoscopic view of a surgical microscope, converts it to a three-dimensional, high-definition digital image, and displays it on a projection screen. The technology, according to surgeons who have used it, affords a defined depth of field, offers the ability to play back and share images, and results in less neck and back strain. 2008-09-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/372008/548854null XML http://www.modernmedicine.com/modernmedicine/Cataract/Study-finds-trends-in-postop-endophthalmitis/ArticleStandard/Article/detail/543127?contextCategoryId=416&ref=25 Postoperative endophthalmitis in an Asian population develops more often in left eyes, among men, and following phacoemulsification, according to an epidemiologic study of cases over 7 years conducted in Singapore. 2008-08-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/342008/543127null HTML http://www.modernmedicine.com/modernmedicine/Ophthalmology/Polymeric-device-may-reduce-risk-of-infection-in-d/ArticleStandard/Article/detail/545074?contextCategoryId=416&ref=25 Researchers at the University of Washington, Seattle, have developed a novel polymeric intraocular drug delivery system for efficient, cost-effective administration of antibiotics following cataract surgery. The group designed the device for markets in developing countries where limited access to medication and adherence issues increase the risk of postoperative infection. 2008-08-15T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/352008/545074null XML http://www.modernmedicine.com/modernmedicine/Ophthalmology/Water-tight-wound-closure-paramount-for-reducing-r/ArticleStandard/Article/detail/533851?contextCategoryId=416&ref=25 To reduce the risk of endophthalmitis after cataract surgery a multimodal approach is needed. Assuring a water-tight wound closure without the use of stromal hydration and use of a fourth-generation fluoroquinolone are two important factors. An analysis of data from patients undergoing clear corneal cataract extraction at the University of Texas Southwestern Medical Center supports these recommendations. 2008-08-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322008/533851null XML http://www.modernmedicine.com/modernmedicine/Ophthalmology/Intraoperative-floppy-iris-syndrome-continues-to-c/ArticleStandard/Article/detail/533852?contextCategoryId=416&ref=25 Results of a recent survey by the American Society of Cataract and Refractive Surgery Cataract Clinical Committee provide insight into the clinical issues facing cataract surgeons and their patients taking alpha blocker drugs. Intraoperative floppy iris syndrome continues to challenge cataract surgeons and especially seems to be associated with tamsulosin (Flomax, Boehringer Ingelheim Pharmaceuticals), according to respondents. 2008-08-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322008/533852null XML http://www.modernmedicine.com/modernmedicine/Ophthalmology/Initiative-aims-to-educate-primary-care-physicians/ArticleStandard/Article/detail/533853?contextCategoryId=416&ref=25 Before prescribing alpha blocker treatment, a primary care physician (PCP) should consider involving the cataract surgeon when treating a patient with a known diagnosis of cataract. So says an educational statement that is part of an initiative by the American Society of Cataract and Refractive Surgery and the American Academy of Ophthalmology launched to further educate PCPs about the connection between alpha blockers, such as tamsulosin (Flomax, Boehringer Ingelheim Pharamceuticals), and intraoperative floppy iris syndrome during cataract surgery. 2008-08-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/322008/533853null XML http://www.modernmedicine.com/modernmedicine/Cataract/Textured-surgical-gloves-implicated-in-TASS-outbre/ArticleStandard/Article/detail/527007?contextCategoryId=416&ref=25 Toxic anterior segment syndrome (TASS) outbreaks occurring at four cataract surgery centers in Canada launched a comprehensive investigation to identify the possible cause(s). Use of a specific brand of textured surgical gloves (Triumph LT, Medline) was identified as a factor, and new cases of TASS have been avoided since use of that particular product was discontinued. 2008-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/272008/527007null XML http://www.modernmedicine.com/modernmedicine/Cataract/Integrated-phaco-platform-facilitates-safe-catarac/ArticleStandard/Article/detail/527015?contextCategoryId=416&ref=25 The internal controls and responsiveness to changes in vacuum with a new integrated phacoemulsification platform (Stellaris Vision Enhancement System, Bausch & Lomb) have made high-vacuum coaxial microincision surgery a safe and efficient procedure. The system also helps decrease the amount of excess energy added to the eye beyond what is needed to remove a cataract. 2008-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/272008/527015null XML http://www.modernmedicine.com/modernmedicine/Cataract/Tools-techniques-help-phaco-in-shallow-anterior-ch/ArticleStandard/Article/detail/527017?contextCategoryId=416&ref=25 Micro transscleral pars plana vitrectomy using high-speed, 25-gauge instruments is an effective new way to handle an old challenge: performing phacoemulsification in patients with very shallow anterior chambers. 2008-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/272008/527017null XML http://www.modernmedicine.com/modernmedicine/Cataract/Cataract-develops-infrequently-after-implantation-/ArticleStandard/Article/detail/527022?contextCategoryId=416&ref=25 The incidence of the development of cataracts is low after implantation of an implantable collamer lens (ICL), 1.96% over 5 years of follow-up. The common risk factors for cataract development in association with an ICL are patients aged more than 40 years, high myopia, surgeon learning curve, shallow anterior chamber depth, and male gender. 2008-07-01T04:00:00Z http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/data/articlestandard/ophthalmologytimes/272008/527022null XML